CHOSA (CHOSA) | Spotlight

Chosa Oncology, Danish -Swedish biotechnology company, has developed the iCIP platform, which includes a liposomal formulation of cisplatin (LiPlaCis) and the companion diagnostic (DRP) tool detecting patients who benefits the most of the cisplatin treatment. The recently achieved clinical phase 2b results mean that the Company is now gearing up the business development activities to find partners for partnership or trade deal.

Quotes for CHOSA Oncology AB

Right Now

+/-: 0.05
%: 5,85%
Latest: 0.905
High: 0.935
Low: 0.735
Volume: 198 210
Turnover (SEK): 175 553
Market Value (MSEK): 71,4
Time (Latest trade): 2025-09-01 17:29

Board

CEO

Peter Buhl

Chairperson of the Board

Ingrid Atteryd Heiman

Board

Claus Frisenberg Pedersen
Fred Hirsch
Morten Myrhøj
Neil Goldsmith
Ulla Hald Buhl

Articles of association

News

2025-08-28 08:30:00 CHOSA Oncology AB – Kvartalsrapport april-juni 2025.
2025-08-08 08:00:00 CHOSA’s presents data on the carboplatin response predictor in breast cancer patients on the annual ESMO conference
2025-08-08 08:00:00 CHOSA presenterar data om carboplatin-responsprediktorn för bröstcancerpatienter på den årliga ESMO-kongressen
2025-08-01 14:29:16 Chosa Oncologys teckningsoptioner av serie TO 2 tas upp till handel
2025-08-01 14:29:16 Chosa Oncology’s warrants of series TO 2 to be admitted to trading

News agencies

2025-08-28 08:51:23 Finwire: Chosa Oncology redovisar som väntat små förändringar av resultatet - siktar på att dela data i Q3
2025-08-08 10:14:20 Finwire: Chosa Oncology presenterar nya data vid ESMO i oktober – potential att förutse effekt av carboplatin vid bröstcancer
2025-07-31 16:35:13 Direkt: AKTIEN HANDELSSTOPPAD AV SPOTLIGHT (R)
2025-07-31 16:23:12 Finwire: Chosa BTU handelsstoppad (R)
2025-07-31 16:21:11 Direkt: AKTIEN HANDELSSTOPPAD AV SPOTLIGHT

Analysis

Largest Owners

Name	Capital %	Votes %	Date
Buhl Krone Holding ApS	22,04	22,04	2025-06-26
Claus Frisenberg Pedersen	11,68	11,68	2023-01-18
IPO Nordic Fund A/S	8,36	8,36	2025-06-26
Smerud Medical Research International AS	7,48	7,48	2025-06-26
Rutger Arnhult	5,48	5,48	2025-06-26
Nels Holding Aps	4,00	4,00	2025-06-26
Lh\|Lh Invest Aps	2,97	2,97	2025-06-26
Karsgaard Holding Ostervra Aps	2,36	2,36	2025-06-26
Sorgenfri Nr. 1 A/S	2,18	2,18	2025-06-26
Xiaoliang Wu	1,88	1,88	2025-06-26

** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

CHOSA Oncology AB